This study will be a randomized clinical trial. A total of 150 women, aged 40 to 60 years, who have reached menopause no longer than 3 years prior to the study, and are willing to cooperate, will participate in the study. After giving informed consent, the subjects will complete the Female Sexual Function Index (FSFI) questionnaire, the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire, the Menopause Rating Scale (MRS), and a researcher-made questionnaire about personal and marital relationship. Blood samples will, also, be taken to check the sex hormones (total testosterone, DHEAS, SHBG, and estradiol) of the subjects. To encourage the subjects to participate, their blood sugar, triglycerides, total cholesterol, LDL, and HDL, will be measured. The subjects, then, will be randomly divided into three groups of 50 members: a group performing Kegel exercises (intervention group), a group being trained on sex issues related to menopause (intervention group), and a group being trained on general issues related to menopause (control group). These three groups will participate in their respective training sessions. Apart from receiving the necessary trainings, the subjects will be given educational booklets. The members of the group performing Kegel exercises will receive a daily exercise checklist. The intervention groups will be monitored weekly by phone calls. After 12 weeks, all participants will complete the questionnaires again and blood samples will be taken from them for hormone testing. The data acquired before and after the intervention in the three groups will be analyzed.